Research and Markets has announced the addition of Pain Therapeutics - Drugs, Markets and Companies to their offering.
This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brain imaging.
Over 200 companies have been identified to be involved in developing or marketing pain therapeutics and 106 of these are profiled in the report along with 79 collaborations. These are a mix of pharmaceutical companies and biotechnology companies. Important collaborations in this area are shown.
The worldwide analgesic market was worth $38 billion during the year 2002 and is expected to nearly double to $75 billion by the year 2010. Calculations are based on the epidemiology of various painful conditions. Unfulfilled needs for analgesics are identified and strategies are outlined to develop markets for analgesic drugs.
Mehr Infos finden sich hier.